PCI Pharma Services (“PCI” or the “Company”), a world-leading global contract development and manufacturing organization (CDMO) focused on innovative biotherapies, today announced that it received a ...

More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...

Bain and Kohlberg are leading an investment round in PCI Pharma Services, valuing it at $10 billion, as AI accelerates drug ...

Mubadala’s investment is part of a strategic transaction co-led by Bain Capital and existing lead investor Kohlberg ...

Dubai: The Abu Dhabi investment firm Mubadala is putting in more funds into US-based PCI Pharma services, a leading player in ...

Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

(Alliance News) - Partners Group Private Equity Ltd on Tuesday said its investment manager, Partners Group Holding AG, has agreed to exit its existing stake in PCI Pharma Services and reinvest as a ...

Private-credit firms tend to accept much higher loan-to-value ratios than banks, raising default risks, Moody's says. Bank of New York Mellon logged higher-than-expected earnings and revenue in the ...

Crypto Assets Rally Ahead of Possible U.S. Legislation Crypto is continuing its bull run at the start of what has been dubbed "Crypto Week" in Washington, where the House of Representatives will ...

Business & Finance ...

A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.